areas for further development include vaccines for influenza ( living , attenuated virus ) , the herpes group ( varicella : cytomegalovirus ) , respiratory syncytial virus , rotavirus and hepatitis a , b , and non a/non b .
C0042776
virus
C0035870
rotavirus